CoChat

Alterations in Gastrointestinal, Endocrine, and Metabolic Processes After Bariatric Roux-en-Y Gastric Bypass Surgery

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Obesity leads to severe long-term complications and reduced life expectancy. Roux-en-Y gastric bypass (RYGB) surgery induces excessive and continuous weight loss in (morbid) obesity, although it causes several abnormal anatomical and physiological conditions. RESEARCH DESIGN AND METHODS: To distinctively unveil effects of RYGB surgery on β-cell function and glucose turnover in skeletal muscle, liver, and gut, nondiabetic, morbidly obese patients were studied before (pre-OP, five female/one male, BMI: 49 ± 3 kg/m2, 43 ± 2 years of age) and 7 ± 1 months after (post-OP, BMI: 37 ± 3 kg/m2) RYGB surgery, compared with matching obese (CONob, five female/one male, BMI: 34 ± 1 kg/m2, 48 ± 3 years of age) and lean controls (CONlean, five female/one male, BMI: 22 ± 0 kg/m2, 42 ± 2 years of age). Oral glucose tolerance tests (OGTTs), hyperinsulinemic-isoglycemic clamp tests, and mechanistic mathematical modeling allowed determination of whole-body insulin sensitivity (M/I), OGTT and clamp test β-cell function, and gastrointestinal glucose absorption. RESULTS: Post-OP lost (P < 0.0001) 35 ± 3 kg body weight. M/I increased after RYGB, becoming comparable to CONob, but remaining markedly lower than CONlean (P < 0.05). M/I tightly correlated (τ = −0.611, P < 0.0001) with fat mass. During OGTT, post-OP showed ≥15% reduced plasma glucose from 120 to 180 min (≤4.5 mmol/L), and 29-fold elevated active glucagon-like peptide-1 (GLP-1) dynamic areas under the curve, which tightly correlated (r = 0.837, P < 0.001) with 84% increased β-cell secretion. Insulinogenic index (0–30 min) in post-OP was ≥29% greater (P < 0.04). At fasting, post-OP showed approximately halved insulin secretion (P < 0.05 vs. pre-OP). Insulin-stimulated insulin secretion in post-OP was 52% higher than before surgery, but 1–2 pmol/min2 lower than in CONob/CONlean (P < 0.05). Gastrointestinal glucose absorption was comparable in pre-OP and post-OP, but 9–26% lower from 40 to 90 min in post-OP than in CONob/CONlean (P < 0.04). CONCLUSIONS: RYGB surgery leads to decreased plasma glucose concentrations in the third OGTT hour and exaggerated β-cell function, for which increased GLP-1 release seems responsible, whereas gastrointestinal glucose absorption remains unchanged but lower than in matching controls.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc12-0197

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Plasma concentrations of glucose (A), insulin (B), C-peptide (C), and FFAs (D) during OGTT in obese patients before (pre-OP; n = 6; ■) and after RYGB surgery (post-OP; n = 6; □), as well as matching obese (CONob; n = 6; ●) and lean controls (CONlean; n = 6; ○), which were previously presented (3). Kruskal-Wallis test: *P < 0.05, pre-OP vs. post-OP; §P < 0.05, pre-OP vs. CONob; &P < 0.05, pre-OP vs. CONlean; #P < 0.05, post-OP vs. CONob; €, post-OP vs. CONlean.
Figure 1 Plasma concentrations of glucose (A), insulin (B), C-peptide (C), and FFAs (D) during OGTT in obese patients before (pre-OP; n = 6; ■) and after RYGB surgery (post-OP; n = 6; □), as well as matching obese (CONob; n = 6; ●) and lean controls (CONlean; n = 6; ○), which were previously presented (3). Kruskal-Wallis test: *P < 0.05, pre-OP vs. post-OP; §P < 0.05, pre-OP vs. CONob; &P < 0.05, pre-OP vs. CONlean; #P < 0.05, post-OP vs. CONob; €, post-OP vs. CONlean.CC BY-NC-ND · PubMed Central
Figure 2 Correlation of OGTT GLP-1 and C-peptide ΔAUCs (A), OGTT IGI (0–30 min) (B), slope of clamp test insulin release (C), and OGTT gut glucose absorption (D), as well as correlations of M/I with body fat mass (E), basal insulin secretion (F), and insulin secretion at clamp end (in percent change relative to baseline) (G), in obese patients before (pre-OP; n = 6; ■ or black columns) and after RYGB surgery (post-OP; n = 6; □ or dark-gray columns), as well as matching obese (CONob; n = 6; ● or light-gray columns) and lean controls (CONlean; n = 6; ○ or white columns). Kruskal-Wallis test: ★P < 0.05, pre-OP vs. post-OP; §P < 0.05, pre-OP vs. CONob; &P < 0.05, pre-OP vs. CONlean; #P < 0.05, post-OP vs. CONob; €, post-OP vs. CONlean; $P < 0.05, CONob vs. CONlean.
Figure 2 Correlation of OGTT GLP-1 and C-peptide ΔAUCs (A), OGTT IGI (0–30 min) (B), slope of clamp test insulin release (C), and OGTT gut glucose absorption (D), as well as correlations of M/I with body fat mass (E), basal insulin secretion (F), and insulin secretion at clamp end (in percent change relative to baseline) (G), in obese patients before (pre-OP; n = 6; ■ or black columns) and after RYGB surgery (post-OP; n = 6; □ or dark-gray columns), as well as matching obese (CONob; n = 6; ● or light-gray columns) and lean controls (CONlean; n = 6; ○ or white columns). Kruskal-Wallis test: ★P < 0.05, pre-OP vs. post-OP; §P < 0.05, pre-OP vs. CONob; &P < 0.05, pre-OP vs. CONlean; #P < 0.05, post-OP vs. CONob; €, post-OP vs. CONlean; $P < 0.05, CONob vs. CONlean.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Anderwald, 2010, Adipotoxicity revisited: shifting from metabolic to cardiometabolic risk profile, Journal of Clinical Metabolism & Diabetes, 1, 61

Cited by

See all 51

Metadata

Authors
Anderwald, C.-H., Tura, A., Promintzer-Schifferl, M., Prager, G., Stadler, M., Ludvik, B., Esterbauer, H., Bischof, M. G., Luger, A., Pacini, G., & Krebs, M.
Affiliations
  • National Research Council (IT)
  • Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
  • Medical University of Vienna (AT)
  • Queen Mary University of London (GB)
Corresponding author
Anderwald, Christian-Heinz
Venue
Diabetes Care
Published
2012-11-14
Volume
35
Issue
12
Pages
2580-2587
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1972301694
Cited by
51
References
31
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 3 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 10 · 2012: 2
FWCI
7.17
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Keywords
Roux-en-Y gastric bypass, morbid obesity, bariatric surgery, insulin sensitivity, beta-cell function, glucose turnover, glucagon-like peptide-1, fat mass, insulin secretion, skeletal muscle glucose uptake, hepatic glucose production, hepatic glucose uptake, postprandial blood glucose, weight loss, obesity complications
MeSH terms
Adult, Blood Glucose, Female, Glucose Tolerance Test, Humans, Male, Middle Aged, Gastric Bypass, Gastrointestinal Tract, Insulin-Secreting Cells, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.